Vivix For COPD. Macular Degeneration and COPD: Progress observed by Debbie Garrison from Early May 2010 through September 2011
Original Message Vivix For COPD
From: Bob Ferguson Bob@FergusonLeadersUnlimited.com
To: Kromer, Johnny
Sent: Sunday, July 07, 2013 1:50 PM
Here’s a testimonial passed along by Fredda Shuquist. Pretty impressive! Also a letter attached from an internist in Master Coordinator Linda Causey’s group. Our products work for everyone, and particularly stressed medical professionals! I think we might do well to be a little more bold in getting the word out to the medical professionals we see, or even ones we don’t!
Best wishes and happy 4th of July weekend.
Roy and Mary contacted me after their Chiropractor recommended Vivix. Roy was on oxygen and a nebulizer. He had COPD, chronic bronchitis, and never left the house without a mask because his immune system was so weak.
In addition,Roy could not see at all out of one eye, and had to use a magnifying glass to read anything out of the other eye.His ophthalmologist had done numerous surgeries trying to delay blindness. Roy also had chronic blood blisters that could only heal if they were pricked by a needle followed by steroid cream.
His hands and forearms were covered with thick, scaly, itchy dark brown skin. Roy and Mary asked me to recommend some products to help with all these problems. Roy had read through the summary of VIVIX research that I had provided for him and was confident that Shaklee products would help him. After all, his chiropractor had gotten rid of ulcerative colitis —and that gave Roy great hope.
Roy and Mary are on a tight budget, so in the beginning they asked for minimum amounts, asking me what amount I thought would give him some results. Then once they saw results, they would up the quantity levels.
I recommended Nutriferon to boost his immune system 2/day; Vitalizer, one strip a day; Optiflora 1 pearl a day; Vivix, 1 tsp a day; 2 zinc/day, 2 Carotomax a day. They asked me to look at the label of the pills his eye doctor recommended and replace them with Shaklee, which is the reason for these amounts.
After 6 weeks, all the dark, scaly skin disappeared from one hand and forearm, and 75% of gone on the other hand and forearm. After 2 months the oxygen and nebulizer equipment was removed from the home. His Internal Medicine Doctor wanted to know “WHAT IN THE WORLD are you doing”?
After 3.5 months Roy visited his ophthalmologist for his 4-month check-up. The Doctor looked up from his computer screen after he had tested Roy’s eyes and exclaimed, “Your vision has improved! What are you doing?!!” You see, this Doctor had never seen a macular degeneration patient’s sight improve.
As of September 15, 2010, Roy can see out of both eyes almost equally. He can read anything he wants to read—he does not have to use a magnifying glass. His lung capacity continues to improve, and we are working on his immune system so that he can go out in public without having to wear the mask.
He is now taking the following supplement amounts each day: 4 Nutriferon, 2 Vitalizer strips, 1 Optiflora pearl, 2 zinc, 2 Carotomax, 2 teaspoons of Vivix and one Cinch shake (now Life Shake 180).
Roy and Mary visited Dr. Issa in Blue Ridge a week ago. Dr. Issa told Mary that she no longer had Adult On-Set Diabetes. She started taking Shaklee in August. I recommended the Cinch  3-in-1 Boost and Cinch  shakes or meal bars to help balance her blood sugar, and explained to her at that time that MANY Shaklee Cinch  customers had gotten off all their diabetes medications
using CINCH . Mary also used Vitalizer and VIVIX.
Dr. Issa also told Roy that he no longer has C.O.P.D. Roy’s opthamologist told him the third weekend in December that his macular degeneration had completely reversed. To everyone in the office’s astonishment, Roy read EVERY Line on the eye chart without any glasses!!
How Resveratrol, Feature of Red Wine, Works to Fight Bacteria-linked Lung Inflammation Detailed in Study
A component of red wine and grapes, resveratrol, was seen to halt the pathogen-induced inflammation common in respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma.
The study, “Resveratrol suppresses NTHi-induced inflammation via up-regulation of the negative regulator MyD88 short,” was published in the online journal Scientific Reports.
Resveratrol belongs to a group of compounds called polyphenols, which are found abundantly in natural plant food sources. The benefits of resveratrol and other polyphenols are linked to their antioxidant properties (i.e., by inhibiting the oxidation of other molecules, these compounds prevent the formation of free radicals, which damage cells). For this reason, resveratrol has long been considered a therapeutic agent for various diseases, including inflammatory diseases.
A team of researchers at Georgia State University studied the effect of resveratrol against inflammation caused by nontypeable Haemophilus influenzae (NTHi), a major respiratory pathogen. In fact, NTHi is a common pathogen colonizing the respiratory tract of asthma and COPD patients, seriously aggravating their condition.
Scientists performed in vitro and in vivo studies, and found that resveratrol significantly decreased NTHi-induced inflammation in both airway epithelial cells and mice lungs. Specifically, the team discovered the molecular mechanism behind this beneficial effect: resveratrol enhances the expression of MyD88 short, a key factor halting inflammation. These results support the therapeutic potential of resveratrol against inflammation associated with chronic airway disease.
“We showed that an important component in red wine and also grapes called resveratrol can suppress inflammation,” said Dr. Jian-Dong Li, the study’s lead author, director of the Institute for Biomedical Sciences at Georgia State and a Georgia Research Alliance Eminent Scholar, in a press release. “It has been shown that resveratrol can suppress inflammation, but how it regulates inflammation still remains largely unknown. We found that resveratrol suppresses a major bacterial pathogen causing otitis media and COPD by upregulating or increasing the production of a negative regulator called MyD88 short.
“The findings help us to shed light on developing new therapeutic strategies by targeting or pharmacologically upregulating MyD88 short production,” Li added. “We could use resveratrol to suppress inflammation or develop resveratrol derivatives that could be pharmacological agents to suppress inflammation using the same strategy.”